Protean behavior by agonists: agonist-directed trafficking of receptor signaling

被引:7
作者
Brink, CB [1 ]
机构
[1] Potchefstroom Univ Christian Higher Educ, Div Pharmacol, ZA-2520 Potchefstroom, South Africa
关键词
D O I
10.1016/S0165-6147(02)02079-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:454 / 455
页数:2
相关论文
共 10 条
[1]   Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus [J].
Berg, KA ;
Maayani, S ;
Goldfarb, J ;
Scaramellini, C ;
Leff, P ;
Clarke, WP .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :94-104
[2]  
Brink CB, 2000, J PHARMACOL EXP THER, V294, P539
[3]  
Chidiac P, 2002, METHOD ENZYMOL, V343, P3
[4]   AGONIST-RECEPTOR EFFICACY .2. AGONIST TRAFFICKING OF RECEPTOR SIGNALS [J].
KENAKIN, T .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (07) :232-238
[5]   PHARMACOLOGICAL PROTEUS [J].
KENAKIN, T .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (08) :256-258
[6]   Inverse, protean, and ligand-selective agonism: matters of receptor conformation [J].
Kenakin, T .
FASEB JOURNAL, 2001, 15 (03) :598-611
[7]  
LANG G, 1999, MOL PHARMACOL, V56, P651
[8]   A three-state receptor model of agonist action [J].
Leff, P ;
Scaramellini, C ;
Law, C ;
McKechnie, K .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (10) :355-362
[9]   Evidence for protean agonism of RX 831003 at α2A-adrenoceptors by co-expression with different Gα protein subunits [J].
Pauwels, PJ ;
Rauly, I ;
Wurch, T ;
Colpaert, FC .
NEUROPHARMACOLOGY, 2002, 42 (06) :855-863
[10]  
Scaramellini C, 2002, METHOD ENZYMOL, V343, P17